ABN AMRO Bank N.V. Buys Shares of 104,367 Welltower Inc. $WELL

ABN AMRO Bank N.V. purchased a new stake in Welltower Inc. (NYSE:WELL) during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm purchased 104,367 shares of the real estate investment trust’s stock, valued at approximately $18,510,000.

Other large investors also recently modified their holdings of the company. Global Wealth Strategies & Associates bought a new position in shares of Welltower during the 3rd quarter worth about $36,000. Newbridge Financial Services Group Inc. increased its position in shares of Welltower by 39.5% during the 2nd quarter. Newbridge Financial Services Group Inc. now owns 307 shares of the real estate investment trust’s stock worth $47,000 after purchasing an additional 87 shares in the last quarter. Copia Wealth Management acquired a new stake in Welltower during the 2nd quarter valued at $51,000. NewSquare Capital LLC grew its holdings in Welltower by 30.2% during the 2nd quarter. NewSquare Capital LLC now owns 362 shares of the real estate investment trust’s stock worth $56,000 after acquiring an additional 84 shares during the last quarter. Finally, Salomon & Ludwin LLC bought a new position in Welltower in the 3rd quarter valued at $59,000. 94.80% of the stock is currently owned by institutional investors and hedge funds.

Welltower Price Performance

Shares of NYSE:WELL opened at $185.52 on Thursday. The firm’s fifty day moving average is $189.88 and its 200-day moving average is $179.65. The company has a debt-to-equity ratio of 0.43, a quick ratio of 5.47 and a current ratio of 5.47. The firm has a market cap of $127.33 billion, a PE ratio of 127.94, a price-to-earnings-growth ratio of 1.30 and a beta of 0.85. Welltower Inc. has a 52 week low of $130.29 and a 52 week high of $209.05.

Analyst Ratings Changes

WELL has been the topic of a number of recent research reports. Jefferies Financial Group reaffirmed a “buy” rating and issued a $231.00 price objective on shares of Welltower in a research note on Monday, December 15th. Weiss Ratings reaffirmed a “buy (b-)” rating on shares of Welltower in a research report on Monday, December 29th. Wall Street Zen upgraded Welltower from a “sell” rating to a “hold” rating in a report on Friday, January 23rd. Cantor Fitzgerald reissued an “overweight” rating and set a $204.00 price target on shares of Welltower in a research report on Monday, January 5th. Finally, UBS Group lowered their target price on Welltower from $232.00 to $228.00 and set a “buy” rating on the stock in a research note on Thursday, January 8th. One equities research analyst has rated the stock with a Strong Buy rating, eleven have assigned a Buy rating, two have given a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $204.80.

Welltower Company Profile

Welltower Inc (NYSE: WELL) is a real estate investment trust (REIT) that acquires and manages real estate serving the health care industry. The company specializes in healthcare infrastructure, owning and operating a diversified portfolio of senior housing, post-acute and long-term care communities, and outpatient medical properties. Welltower’s assets are designed to support the delivery of health care services through a combination of leased properties, joint ventures, and other capital arrangements with health care operators and providers.

The company’s property types include assisted living, memory care, independent living and skilled nursing facilities, as well as medical office buildings and other outpatient-care real estate such as ambulatory surgery centers and specialty clinics.